Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of Warrants Outstanding (Details)

Stockholders' Equity - Schedule of Warrants Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Warrants outstanding, Weighted-average remaining contractual life ( in years)	2 years	3 years
Warrant [Member]
Number of warrants, outstanding	9,506,304
Number of warrants exercisable	9,506,304
Range 1 [Member] \| Warrant [Member]
Range of exercise prices, upper limit	$ 5.00
Number of warrants, outstanding	7,439,631
Warrants outstanding, Weighted-average remaining contractual life ( in years)	1 year 9 months 18 days
Number of warrants exercisable	7,439,631
Range 2 [Member] \| Warrant [Member]
Range of exercise prices, lower limit	$ 4.00
Range of exercise prices, upper limit	$ 4.99
Number of warrants, outstanding
Warrants outstanding, Weighted-average remaining contractual life ( in years)	0 years
Number of warrants exercisable
Range 3 [Member] \| Warrant [Member]
Range of exercise prices, lower limit	$ 3.00
Range of exercise prices, upper limit	$ 3.99
Number of warrants, outstanding	799,901
Warrants outstanding, Weighted-average remaining contractual life ( in years)	2 years 7 months 6 days
Number of warrants exercisable	799,901
Range 4 [Member] \| Warrant [Member]
Range of exercise prices, lower limit	$ 2.00
Range of exercise prices, upper limit	$ 2.99
Number of warrants, outstanding	954,272
Warrants outstanding, Weighted-average remaining contractual life ( in years)	3 years 7 months 6 days
Number of warrants exercisable	954,272
Range 5 [Member] \| Warrant [Member]
Range of exercise prices, lower limit	$ 1.00
Range of exercise prices, upper limit	$ 1.99
Number of warrants, outstanding	312,500
Warrants outstanding, Weighted-average remaining contractual life ( in years)	4 years
Number of warrants exercisable	312,500